When the national Medicare coverage policy was set for transcatheter aortic valve replacements (TAVR) in 2012, it specified a minimum number of heart-valve surgeries, percutaneous coronary interventions and other types of procedures that hospitals and physicians must have under their belts to maintain a TAVR program sanctioned by the public-payer program.
The baseline requirements were one key element that have driven product rollout strategies for Edwards Lifesciences Corp. and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?